Year: 2026
Type: preprint
Abstract: Background & Aims Most prognostic models for metabolic dysfunction-associated steatotic liver disease (MASLD) target prespecified hepatic endpoints, potentially limiting attainable accuracy. We developed and externally validated a model that learns the future hepatic phenotype most reliably predictable from baseline clinical characteristics. Methods We analyzed 332 HALO-MASLD participants (456 follow-up observations). Sparse Canonical Outcome REgression (SCORE) learned a weighted phenotype from eight hepatic measures, coupled with broken adaptive ridge regression using 99 baseline predictor columns. Participant-level nested five-fold cross-validation compared prediction of the learned phenotype with future liver stiffness measurement (LSM), controlled attenuation parameter (CAP), and FIB-4 benchmarks. Models were externally validated without refitting in the independent NIDDK NAFLD Adult Database 2 cohort (520 participants, 732 follow-up observations). Biological validity and bootstrap stability were also assessed. Results The learned phenotype emphasized lower platelet count and higher bilirubin, alkaline phosphatase, and LSM. In HALO, predictive correlation was r = 0.860 (95% CI [0.824, 0.896]) and predictive R 2 = 0.671, versus r = 0.763 for LSM and r = 0.469 for CAP predicted from all baseline variables. All six prespecified comparisons remained significant after Holm correction ( p Holm < 0.05). The phenotype correlated with MRE stiffness ( ρ = 0.694) and biopsy fibrosis stage ( ρ = 0.567), and was higher with imaging evidence of portal hypertension ( p < 0.001). Bootstrap relearning yielded mean phenotype correlation 0.947. In NIDDK, predictive correlation was r = 0.836 (95% CI [0.805, 0.863]; predictive R 2 = 0.680), and associations with fibrosis and portal hypertension replicated. Conclusions Learning the prediction target produced a sparse, clinically interpretable hepatic phenotype more accurately predicted than conventional longitudinal MASLD endpoints in both cohorts. The resulting LIFT-MASLD model is available at https://liftmasld.github.io .
Source: medRxiv
Institution: University of Pittsburgh
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235471650
